[HTML][HTML] Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 …
J Petiti, M Lo Iacono, M Dragani, L Pironi… - Journal of clinical …, 2020 - mdpi.com
BCR-ABL1 fusion transcript is the minimal residual disease marker in chronic myeloid
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 Transcripts.
J Petiti, M Lo Iacono, M Dragani… - Journal of Clinical …, 2020 - search.ebscohost.com
BCR-ABL1 fusion transcript is the minimal residual disease marker in chronic myeloid
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
[PDF][PDF] Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 …
J Petiti, ML Iacono, M Dragani, L Pironi, C Fantino… - J. Clin. Med, 2020 - researchgate.net
BCR-ABL1 fusion transcript is the minimal residual disease marker in chronic myeloid
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
[PDF][PDF] Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 …
J Petiti, M Lo Iacono, M Dragani, L Pironi… - JOURNAL OF …, 2020 - iris.inrim.it
BCR-ABL1 fusion transcript is the minimal residual disease marker in chronic myeloid
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
[PDF][PDF] Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 …
J Petiti, ML Iacono, M Dragani, L Pironi, C Fantino… - J. Clin. Med, 2020 - core.ac.uk
BCR-ABL1 fusion transcript is the minimal residual disease marker in chronic myeloid
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
Novel multiplex droplet digital pcr assays to monitor minimal residual disease in chronic myeloid leukemia patients showing atypical bcr-abl1 transcripts
J Petiti, ML Iacono, M Dragani, L Pironi… - JOURNAL OF …, 2020 - iris.unina.it
BCR-ABL1 fusion transcript is the minimal residual disease marker in chronic myeloid
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
[PDF][PDF] Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 …
J Petiti, ML Iacono, M Dragani, L Pironi… - J. Clin …, 2020 - pdfs.semanticscholar.org
BCR-ABL1 fusion transcript is the minimal residual disease marker in chronic myeloid
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
[PDF][PDF] Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 …
J Petiti, ML Iacono, M Dragani, L Pironi, C Fantino… - J. Clin. Med, 2020 - academia.edu
BCR-ABL1 fusion transcript is the minimal residual disease marker in chronic myeloid
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 Transcripts.
J Petiti, L Iacono, M Dragani, L Pironi… - Journal of Clinical …, 2020 - europepmc.org
BCR-ABL1 fusion transcript is the minimal residual disease marker in chronic myeloid
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 Transcripts
J Petiti, ML Iacono, M Dragani, L Pironi… - Journal of Clinical …, 2020 - search.proquest.com
BCR-ABL1 fusion transcript is the minimal residual disease marker in chronic myeloid
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …
leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not …